AI assistant
BiomX Inc. — Director's Dealing 2020
Mar 27, 2020
35099_dirs_2020-03-27_cba6425f-7f94-4073-b1e7-8bbedcb9c282.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2020-03-25
Reporting Person: Puttagunta Sailaja (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-25 | Common Stock Options - Right to Buy | $6.21 | A | 67500 | Acquired | 2030-03-25 | Common Stock (67500) | Indirect |
Footnotes
F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.
F2: Does not include 263,576 additional options previously granted to the Reporting Person which have different exercise prices and which vest on different schedules.
F3: The options are held by SPB Consulting LLC. The Reporting Person is the sole member of SPB Consulting LLC and may be deemed the indirect beneficial owner of the securities held by SPB Consulting LLC.